publication . Article . 2005

A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena

Marylou V. Solbrig; Russell Adrian; Janie Baratta; Daniele Piomelli; Andrea Giuffrida;
Open Access
  • Published: 01 Aug 2005 Journal: Experimental Neurology, volume 194, pages 355-362 (issn: 0014-4886, Copyright policy)
  • Publisher: Elsevier BV
  • Country: United States
Dyskinesias and seizures are both medically refractory disorders for which cannabinoid-based treatments have shown early promise as primary or adjunctive therapy. Using the Borna disease (BD) virus rat, an animal model of viral encephalopathy with spontaneous hyperkinetic movements and seizure susceptibility, we identified a key role for endocannabinoids in the maintenance of a balanced tone of activity in extrapyramidal and limbic circuits. BD rats showed significant elevations of the endocannabinoid anandamide in subthalamic nucleus, a relay nucleus compromised in hyperkinetic disorders. While direct and indirect cannabinoid agonists had limited motor effects ...
Persistent Identifiers
free text keywords: Developmental Neuroscience, Neurology, NLX, Neuroscience, Opioid, medicine.drug, medicine, Cannabinoid receptor, AM404, chemistry.chemical_compound, chemistry, Endocannabinoid system, Psychology, Anticonvulsant, medicine.medical_treatment, Pharmacology, Anandamide, Cannabinoid
Related Organizations
Any information missing or wrong?Report an Issue